Figure 1.
Figure 1. Generation of 32D/BA cells stably or inducibly coexpressing ICSBP. Protein lysates were harvested and immunoblotted with anti-ICSBP, anti-BCR/ABL, and anti-β-actin antibodies. β-actin immunoblotting was performed to assure equal protein loading. (A) 32D cells expressing BCR/ABL, ICSBP, or both, and appropriate vector (v) control cells. (B) ICSBP expression of 32D/ICSBP on/off cells 96 hours to 24 hours before, and 24 hours to 96 hours after addition of 1 μg/mL doxycycline. (C) ICSBP expression of 32D/ICSBP-BA on/off cells 96 hours to 24 hours before, and 24 hours to 96 hours after addition of 1 μg/mL doxycycline (top blot). (Bottom blots) BCR/ABL expression of 32D/ICSBP on/off and 32D/ICSBP-BA on/off cells in presence or absence of ICSBP.

Generation of 32D/BA cells stably or inducibly coexpressing ICSBP. Protein lysates were harvested and immunoblotted with anti-ICSBP, anti-BCR/ABL, and anti-β-actin antibodies. β-actin immunoblotting was performed to assure equal protein loading. (A) 32D cells expressing BCR/ABL, ICSBP, or both, and appropriate vector (v) control cells. (B) ICSBP expression of 32D/ICSBP on/off cells 96 hours to 24 hours before, and 24 hours to 96 hours after addition of 1 μg/mL doxycycline. (C) ICSBP expression of 32D/ICSBP-BA on/off cells 96 hours to 24 hours before, and 24 hours to 96 hours after addition of 1 μg/mL doxycycline (top blot). (Bottom blots) BCR/ABL expression of 32D/ICSBP on/off and 32D/ICSBP-BA on/off cells in presence or absence of ICSBP.

Close Modal

or Create an Account

Close Modal
Close Modal